• Skip to primary navigation
  • Skip to main content

Office for the Protection of Research Subjects

University of Southern CaliforniaResearch
  • Research
  • OPRS​
  • IRB
  • Education & Certification
  • Policies
  • Announcements
  • Contact
You are here: Home / Research / Investigator-Initiated Trials

Investigator-Initiated Trials

Most Investigator-Initiated Trials do not have an industry sponsor. With limited resources and less oversight, investigators face challenges in ensuring compliance with regulations and good clinical practices. Below are guidelines and templates on the responsibilities of investigator initiated/ sponsor-investigator research.

  • FDA Guidance for Investigational Drugs (IND)
  • FDA Guidance for Investigational Devices (IDE)
  • Best Practices in Clinical Research Protocol Writing

USC Resources

  • USC Sponsor-Investigator Agreement
  • Regulatory Science Consulting Services

Protocol Templates

  • NIH Clinical Trial Template (Phase 2, 3)
  • Norris Protocol Template
  • Protocol Template (Cooperative Health System)
  • Protocol Writing Tips (Kinetiq)
  • Organizing a Clinical Trial Binder
  • Phase I Trial Design Tips

Guidance from Other Institutions

  • UCSF Investigational New Drug (IND) Submissions for Sponsor-Investigators
  • UCSF Investigational Device Exemption (IDE) Development Process

OPRS and IRB
3720 S. Flower Street, Suite 325
Los Angeles, CA 90089
oprs@usc.edu
irb@usc.edu
(323) 442-0114

Full Accreditation badge from the Association for the Accreditation of Human Research Protection Programs
University of Southern California   Content managed by OPRS
  • Privacy Notice - Notice of Non-Discrimination